BRIEF published on 06/18/2026 at 07:35, 2 months 10 days ago ABIONYX Pharma successfully completes its capital increase Capital Increase Clinical Trial Bond Financing Sepsis Fenja Capital
BRIEF published on 06/18/2026 at 07:35, 2 months 10 days ago ABIONYX Pharma réussit son augmentation de capital Augmentation De Capital Essai Clinique Financement Obligataire Sepsis Fenja Capital
BRIEF published on 06/18/2026 at 07:35, 2 months 10 days ago ABIONYX Pharma finalise avec succès un financement de 33 millions d'euros. Augmentation De Capital ABIONYX Pharma Fenja Capital Financement Par Obligations Recherche Sur La Septicémie
PRESS RELEASE published on 06/18/2026 at 07:30, 2 months 10 days ago Inside Information / Other news releases ABIONYX Pharma successfully completes financing, raising EUR 33 M. Capital increase and bonds financing secured, enhancing financial position for future growth and clinical trials Financing Clinical Trials Capital Increase ABIONYX Pharma Bonds Financing
PRESS RELEASE published on 06/18/2026 at 07:30, 2 months 10 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce le succès de son financement de 33 M€ pour renforcer son développement clinique et sa trésorerie. Les actionnaires historiques soutiennent l'opération Financement Trésorerie Développement Clinique Actionnaires Historiques ABIONYX Pharma
BRIEF published on 05/28/2026 at 19:11, 2 months 30 days ago ABIONYX Pharma : Bilan du premier trimestre 2026 Chiffre D'affaires Financement Trésorerie Sepsis Thérapies Innovantes
BRIEF published on 05/28/2026 at 19:11, 2 months 30 days ago ABIONYX Pharma Reports Stable First Quarter and Robust Financing for Future Growth Clinical Trials Capital Increase Financial Stability ABIONYX Pharma Revenue 2026
BRIEF published on 05/28/2026 at 19:11, 2 months 30 days ago ABIONYX Pharma annonce un premier trimestre stable et un financement solide pour sa croissance future. Augmentation De Capital Essais Cliniques Stabilité Financière ABIONYX Pharma Recettes 2026
BRIEF published on 05/28/2026 at 19:11, 2 months 30 days ago ABIONYX Pharma: Review of the first quarter of 2026 Revenue Treasury Funding Innovative Therapies Sepsis
PRESS RELEASE published on 05/28/2026 at 19:06, 2 months 30 days ago Inside Information / Other news releases ABIONYX Pharma updates its operations and cash position for Q1 2026. Consolidated revenue of €0.8M, cash reserves of €2.8M. Funding secured till 2028 through capital increase and non-dilutive loan Revenue Cash Position Funding ABIONYX Pharma Q1 2026
Published on 08/28/2026 at 14:00, 3 hours 21 minutes ago Lobe Sciences Expands Leadership Team with New CFO Appointment
Published on 08/28/2026 at 13:00, 4 hours 21 minutes ago Abasca Files NI 43-101 Technical Report, Commences Summer Exploration Program at Loki and Elects to File Semi-annual Interim Financial Statements and Related MD&A
Published on 08/28/2026 at 08:05, 9 hours 16 minutes ago Caledonia Mining Corporation Plc: Maiden Mineral Resource Estimate at Motapa 379,000 oz Measured and Indicated; 131,000 oz Inferred
Published on 08/28/2026 at 08:05, 9 hours 16 minutes ago Tocvan Announces New Surface Mineralization in Several Zones at Gran Pilar Gold-Silver Project
Published on 08/28/2026 at 08:00, 9 hours 21 minutes ago Caledonia Mining Corporation Plc: Blanket Mine Underground Measured and Indicated Mineral Resources Estimate Increases by 22% to 2.18 Million Ounces and Declaration of a Surface Mineral Resource Estimate
Published on 08/28/2026 at 16:50, 31 minutes ago TCL Electronics (01070.HK) Delivers Strong Growth in 2026 Interim Results
Published on 08/28/2026 at 15:55, 1 hour 25 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/28/2026 at 15:55, 1 hour 26 minutes ago Form 8.3 - The Vanguard Group, Inc.: DNO Iraq AS (a wholly owned subsidiary of DNO ASA)
Published on 08/26/2026 at 18:02, 1 day 23 hours ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 1 day 23 hours ago Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 1 day 23 hours ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
